image
Healthcare - Medical - Devices - NASDAQ - US
$ 21.8
-3.96 %
$ 541 M
Market Cap
-13.29
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one KIDS stock under the worst case scenario is HIDDEN Compared to the current market price of 21.8 USD, OrthoPediatrics Corp. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one KIDS stock under the base case scenario is HIDDEN Compared to the current market price of 21.8 USD, OrthoPediatrics Corp. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one KIDS stock under the best case scenario is HIDDEN Compared to the current market price of 21.8 USD, OrthoPediatrics Corp. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart KIDS

image
$31.0$31.0$30.0$30.0$29.0$29.0$28.0$28.0$27.0$27.0$26.0$26.0$25.0$25.0$24.0$24.0$23.0$23.0$22.0$22.0$21.0$21.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
205 M REVENUE
37.65%
-29.5 M OPERATING INCOME
-14.57%
-37.8 M NET INCOME
-80.33%
-27 M OPERATING CASH FLOW
-0.01%
-13.2 M INVESTING CASH FLOW
-31.58%
53.1 M FINANCING CASH FLOW
627.78%
52.7 M REVENUE
-3.49%
-8.57 M OPERATING INCOME
-53.90%
-16.1 M NET INCOME
-102.92%
-3.99 M OPERATING CASH FLOW
61.21%
-2.41 M INVESTING CASH FLOW
90.99%
-541 K FINANCING CASH FLOW
-0.92%
Balance Sheet OrthoPediatrics Corp.
image
Current Assets 237 M
Cash & Short-Term Investments 68.8 M
Receivables 42.4 M
Other Current Assets 126 M
Non-Current Assets 236 M
Long-Term Investments 0
PP&E 50.6 M
Other Non-Current Assets 185 M
14.55 %8.95 %26.62 %10.69 %39.19 %Total Assets$473.2m
Current Liabilities 34 M
Accounts Payable 8.91 M
Short-Term Debt 160 K
Other Current Liabilities 24.9 M
Non-Current Liabilities 50.7 M
Long-Term Debt 24 M
Other Non-Current Liabilities 26.8 M
10.52 %29.40 %28.29 %31.60 %Total Liabilities$84.7m
EFFICIENCY
Earnings Waterfall OrthoPediatrics Corp.
image
Revenue 205 M
Cost Of Revenue 56.1 M
Gross Profit 149 M
Operating Expenses 178 M
Operating Income -29.5 M
Other Expenses 8.3 M
Net Income -37.8 M
250m250m200m200m150m150m100m100m50m50m00(50m)(50m)205m(56m)149m(178m)(30m)(8m)(38m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
72.58% GROSS MARGIN
72.58%
-14.42% OPERATING MARGIN
-14.42%
-18.47% NET MARGIN
-18.47%
-10.67% ROE
-10.67%
-7.99% ROA
-7.99%
-6.06% ROIC
-6.06%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis OrthoPediatrics Corp.
image
00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)(25m)(25m)(30m)(30m)(35m)(35m)(40m)(40m)(45m)(45m)(50m)(50m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -37.8 M
Depreciation & Amortization 19.1 M
Capital Expenditures -14.3 M
Stock-Based Compensation 13.5 M
Change in Working Capital -22.9 M
Others 5.11 M
Free Cash Flow -41.3 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets OrthoPediatrics Corp.
image
Wall Street analysts predict an average 1-year price target for KIDS of $37.4 , with forecasts ranging from a low of $28 to a high of $44 .
KIDS Lowest Price Target Wall Street Target
28 USD 28.44%
KIDS Average Price Target Wall Street Target
37.4 USD 71.44%
KIDS Highest Price Target Wall Street Target
44 USD 101.83%
Price
Max Price Target
Min Price Target
Average Price Target
454540403535303025252020May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership OrthoPediatrics Corp.
image
Sold
0-3 MONTHS
722 K USD 5
3-6 MONTHS
0 USD 0
6-9 MONTHS
293 K USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference WARSAW, Ind., March 25, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference. globenewswire.com - 2 weeks ago
OrthoPediatrics Corp. Named One the 2025 Best Places to Work in Indiana WARSAW, Ind., March 24, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was selected as one of the 2025 Best Places to Work in Indiana. This is the 9th time the Company has been recognized by the annual program created by the Indiana Chamber of Commerce. globenewswire.com - 2 weeks ago
OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company's cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​ globenewswire.com - 3 weeks ago
OrthoPediatrics Corp. (KIDS) Q4 2024 Earnings Call Transcript OrthoPediatrics Corp. (NASDAQ:KIDS ) Q4 2024 Earnings Conference Call March 4, 2025 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group, IR David Bailey - President and CEO Fred Hite - Chief Operating and Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Rick Wise - Stifel Matthew O'Brien - Piper Sandler Joseph Conway - Needham & Company Operator Hello. And welcome to OrthoPediatrics Corporation's Fourth Quarter and Full Year 2024 Earnings Conference Call. seekingalpha.com - 1 month ago
Compared to Estimates, OrthoPediatrics (KIDS) Q4 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com - 1 month ago
OrthoPediatrics (KIDS) Reports Q4 Loss, Misses Revenue Estimates OrthoPediatrics (KIDS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to loss of $0.23 per share a year ago. zacks.com - 1 month ago
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results Record full year 2024 revenue of $204.7 million increased 38% compared to prior year, and more than doubled fourth quarter 2024 adjusted EBITDA WARSAW, Ind., March 04, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the fourth quarter and full year ended December 31, 2024. globenewswire.com - 1 month ago
SOUR PATCH KIDS® Introduces Glow Ups: The First-Ever Gummy Candy that Glows Under Blacklight The brand's latest innovation features edible confetti containing turmeric extract, which gives it an unforgettable glow EAST HANOVER, N.J. , March 4, 2025 /PRNewswire/ -- The SOUR PATCH KIDS brand is lighting up the candy aisle with its latest innovation: SOUR PATCH KIDS Strawberry-Watermelon Glow Ups, the first-ever gummy candy that glows under blacklight. prnewswire.com - 1 month ago
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 WARSAW, Ind., Feb. 19, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025 after the market closes. OrthoPediatrics will host a conference call on Tuesday, March 4, 2025 at 4:30 p.m. ET to discuss the results. globenewswire.com - 1 month ago
POTTERY BARN KIDS EXPANDS POPULAR MODERN BABY COLLECTION SAN FRANCISCO--(BUSINESS WIRE)--Pottery Barn Kids, a portfolio brand of Williams-Sonoma, Inc. (NYSE: WSM), the world's largest digital-first, design-led and sustainable home retailer, announced today the expansion of the brand's popular Modern Baby collection with 14 design-forward lifestyles. The Modern Baby collection offers distinct aesthetics that each uniquely embrace modern elements of design for a style that is warm and welcoming, while maintaining the brand's signature quality and safet. businesswire.com - 1 month ago
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that the Company gained distribution rights to bring additional bracing solutions to the US market through its OrthoPediatrics Specialty Bracing (OPSB) division. globenewswire.com - 2 months ago
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance Achieves all-time high full year 2024 Revenue of $205 million representing growth of 38% Year-Over-YearInitiates guidance for record adjusted EBITDA in 2025 globenewswire.com - 2 months ago
8. Profile Summary

OrthoPediatrics Corp. KIDS

image
COUNTRY US
INDUSTRY Medical - Devices
MARKET CAP $ 541 M
Dividend Yield 0.00%
Description OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Contact 2850 Frontier Drive, Warsaw, IN, 46582 https://www.orthopediatrics.com
IPO Date Oct. 13, 2017
Employees 562
Officers Ray Garrison Senior Vice President of Quality & Regulatory and Clinical Mr. Daniel J. Gerritzen J.D. Executive Vice President of Legal, General Counsel & Secretary Mr. David R. Bailey President, Chief Executive Officer & Director Mr. Mark C. Throdahl Executive Chairman Mr. Fred L. Hite Chief Financial Officer, Principal Financial & Accounting Officer, Chief Operating Officer and Director Mr. Mark Karshner Senior Vice President of International Sales Mr. Gregory A. Odle President of Scoliosis